R, W., Y, C., J, H., H, Y., H, Y., Q, L., . . . G, L. (2024). Selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failure. Nature communications, 15(1), 10690. https://doi.org/10.1038/s41467-024-55295-7
Chicago Style (17th ed.) CitationR, Wang, et al. "Selectively Targeting the AdipoR2-CaM-CaMKII-NOS3 Axis by SCM-198 as a Rapid-acting Therapy for Advanced Acute Liver Failure." Nature Communications 15, no. 1 (2024): 10690. https://doi.org/10.1038/s41467-024-55295-7.
MLA (9th ed.) CitationR, Wang, et al. "Selectively Targeting the AdipoR2-CaM-CaMKII-NOS3 Axis by SCM-198 as a Rapid-acting Therapy for Advanced Acute Liver Failure." Nature Communications, vol. 15, no. 1, 2024, p. 10690, https://doi.org/10.1038/s41467-024-55295-7.